TrinityPoint Wealth LLC Acquires 253 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

TrinityPoint Wealth LLC increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 22.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,371 shares of the medical equipment provider’s stock after buying an additional 253 shares during the period. TrinityPoint Wealth LLC’s holdings in Intuitive Surgical were worth $716,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of the business. Carnegie Investment Counsel raised its stake in shares of Intuitive Surgical by 33.3% during the 4th quarter. Carnegie Investment Counsel now owns 653 shares of the medical equipment provider’s stock valued at $341,000 after purchasing an additional 163 shares during the period. Wealthcare Advisory Partners LLC raised its stake in shares of Intuitive Surgical by 2.5% during the 4th quarter. Wealthcare Advisory Partners LLC now owns 4,004 shares of the medical equipment provider’s stock valued at $2,090,000 after purchasing an additional 97 shares during the period. Merit Financial Group LLC raised its stake in shares of Intuitive Surgical by 49.7% during the 4th quarter. Merit Financial Group LLC now owns 6,664 shares of the medical equipment provider’s stock valued at $3,478,000 after purchasing an additional 2,213 shares during the period. Sax Wealth Advisors LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at $328,000. Finally, Sanibel Captiva Trust Company Inc. raised its stake in shares of Intuitive Surgical by 46.9% during the 4th quarter. Sanibel Captiva Trust Company Inc. now owns 930 shares of the medical equipment provider’s stock valued at $485,000 after purchasing an additional 297 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research firms recently issued reports on ISRG. Citigroup boosted their price objective on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Wells Fargo & Company boosted their target price on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Truist Financial reduced their target price on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating for the company in a research report on Wednesday, April 23rd. UBS Group boosted their target price on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research report on Monday, January 27th. Finally, Leerink Partners boosted their target price on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Five research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $598.95.

Insider Activity at Intuitive Surgical

In related news, EVP Myriam Curet sold 2,401 shares of the stock in a transaction dated Thursday, February 27th. The stock was sold at an average price of $581.00, for a total transaction of $1,394,981.00. Following the completion of the sale, the executive vice president now directly owns 353 shares in the company, valued at $205,093. This represents a 87.18% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Jamie Samath sold 188 shares of the stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $566.94, for a total value of $106,584.72. Following the sale, the chief financial officer now owns 7,162 shares of the company’s stock, valued at $4,060,424.28. This represents a 2.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 32,700 shares of company stock worth $16,865,621 in the last ninety days. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Trading Up 0.6%

ISRG opened at $563.60 on Monday. The stock has a 50-day moving average price of $505.22 and a 200-day moving average price of $536.84. Intuitive Surgical, Inc. has a 12-month low of $395.60 and a 12-month high of $616.00. The stock has a market capitalization of $202.00 billion, a P/E ratio of 87.93, a PEG ratio of 5.85 and a beta of 1.70.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The firm had revenue of $2.25 billion during the quarter, compared to analysts’ expectations of $2.19 billion. During the same period in the prior year, the business earned $1.50 EPS. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.